Blood advances
Bone marrow transplantation for sickle cell disease using post-transplantation cyclophosphamide and 400 cGy TBI.
Marti Goldenberg, Ravi Varadhan, Christopher J Gamper, Kenneth R Cooke, Alexander J Ambinder, Heather J Symons, Lydia H Pecker, Richard J Jones, Robert A Brodsky, Javier Bolaños-Meade
Published: 202610.1182/bloodadvances.2025017413
Abstract
Reduced intensity conditioning (RIC), haploidentical donors, and post-transplantation cyclophosphamide (PTCy) have overcome many barriers associated with bone marrow transplantation (BMT) for sickle cell disease (SCD). However, initial approaches had…
Preview only. Read the full abstract at the source